ID ADRB1_MOUSE Reviewed; 466 AA. AC P34971; B2RVY4; DT 01-FEB-1994, integrated into UniProtKB/Swiss-Prot. DT 27-JUL-2011, sequence version 2. DT 24-JAN-2024, entry version 191. DE RecName: Full=Beta-1 adrenergic receptor; DE AltName: Full=Beta-1 adrenoreceptor; DE Short=Beta-1 adrenoceptor; GN Name=Adrb1; Synonyms=Adrb1r; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=129/Sv; RX PubMed=8395893; DOI=10.1016/0167-4889(93)90209-8; RA Jasper J.R., Link R.E., Chruscinski A.J., Kobilka B.K., Bernstein D.; RT "Primary structure of the mouse beta 1-adrenergic receptor gene."; RL Biochim. Biophys. Acta 1178:307-309(1993). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP PROTEIN SEQUENCE OF 303-307, AND IDENTIFICATION BY MASS SPECTROMETRY. RC STRAIN=OF1; TISSUE=Hippocampus; RA Lubec G., Sunyer B., Chen W.-Q.; RL Submitted (JAN-2009) to UniProtKB. RN [5] RP MUTAGENESIS OF ALA-187, TISSUE SPECIFICITY, AND FUNCTION. RX PubMed=31473062; DOI=10.1016/j.neuron.2019.07.026; RA Shi G., Xing L., Wu D., Bhattacharyya B.J., Jones C.R., McMahon T., RA Chong S.Y.C., Chen J.A., Coppola G., Geschwind D., Krystal A., Ptacek L.J., RA Fu Y.H.; RT "A rare mutation of beta1-adrenergic receptor affects sleep/wake RT behaviors."; RL Neuron 0:0-0(2019). CC -!- FUNCTION: Beta-adrenergic receptors mediate the catecholamine-induced CC activation of adenylate cyclase through the action of G proteins. This CC receptor binds epinephrine and norepinephrine with approximately equal CC affinity. Mediates Ras activation through G(s)-alpha- and cAMP-mediated CC signaling (By similarity). Involved in the regulation of sleep/wake CC behaviors (PubMed:31473062). {ECO:0000250|UniProtKB:P08588, CC ECO:0000269|PubMed:31473062}. CC -!- SUBUNIT: Interacts (via C-terminus PDZ motif) with RAPGEF2; the CC interaction is direct. Interacts with GOPC, MAGI3 and DLG4 (By CC similarity). {ECO:0000250|UniProtKB:P08588}. CC -!- INTERACTION: CC P34971; P18762: Adrb2; NbExp=2; IntAct=EBI-7764182, EBI-491143; CC P34971; Q01063: Pde4d; NbExp=3; IntAct=EBI-7764182, EBI-7764239; CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P18090}; CC Multi-pass membrane protein {ECO:0000250|UniProtKB:P18090}. Early CC endosome {ECO:0000250}. Note=Colocalizes with RAPGEF2 at the plasma CC membrane. Found in the Golgi upon GOPC overexpression (By similarity). CC {ECO:0000250}. CC -!- TISSUE SPECIFICITY: In brain, expressed by glutamatergic and GABAergic CC neurons of the dorsal pons (at protein level). CC {ECO:0000269|PubMed:31473062}. CC -!- DOMAIN: The PDZ domain-binding motif mediates competitive interactions CC with GOPC, MAGI3 and DLG4 and plays a role in subcellular location of CC the receptor. {ECO:0000250}. CC -!- PTM: Homologous desensitization of the receptor is mediated by its CC phosphorylation by beta-adrenergic receptor kinase. CC -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family. CC Adrenergic receptor subfamily. ADRB1 sub-subfamily. CC {ECO:0000255|PROSITE-ProRule:PRU00521}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; L10084; AAA02929.1; -; Genomic_DNA. DR EMBL; CH466585; EDL01765.1; -; Genomic_DNA. DR EMBL; BC140970; AAI40971.1; -; mRNA. DR EMBL; BC147435; AAI47436.1; -; mRNA. DR CCDS; CCDS29919.1; -. DR PIR; S36794; S36794. DR RefSeq; NP_031445.2; NM_007419.2. DR AlphaFoldDB; P34971; -. DR SMR; P34971; -. DR DIP; DIP-59567N; -. DR IntAct; P34971; 6. DR MINT; P34971; -. DR STRING; 10090.ENSMUSP00000040847; -. DR BindingDB; P34971; -. DR ChEMBL; CHEMBL3440; -. DR GlyCosmos; P34971; 1 site, No reported glycans. DR GlyGen; P34971; 1 site. DR iPTMnet; P34971; -. DR PhosphoSitePlus; P34971; -. DR PaxDb; 10090-ENSMUSP00000040847; -. DR ProteomicsDB; 296186; -. DR Antibodypedia; 31906; 357 antibodies from 37 providers. DR DNASU; 11554; -. DR Ensembl; ENSMUST00000038949.6; ENSMUSP00000040847.5; ENSMUSG00000035283.6. DR GeneID; 11554; -. DR KEGG; mmu:11554; -. DR UCSC; uc008hze.2; mouse. DR AGR; MGI:87937; -. DR CTD; 153; -. DR MGI; MGI:87937; Adrb1. DR VEuPathDB; HostDB:ENSMUSG00000035283; -. DR eggNOG; KOG3656; Eukaryota. DR GeneTree; ENSGT00940000161953; -. DR HOGENOM; CLU_009579_11_0_1; -. DR InParanoid; P34971; -. DR OMA; AGTWSDC; -. DR OrthoDB; 2900736at2759; -. DR PhylomeDB; P34971; -. DR TreeFam; TF316350; -. DR Reactome; R-MMU-390696; Adrenoceptors. DR Reactome; R-MMU-418555; G alpha (s) signalling events. DR BioGRID-ORCS; 11554; 2 hits in 78 CRISPR screens. DR PRO; PR:P34971; -. DR Proteomes; UP000000589; Chromosome 19. DR RNAct; P34971; Protein. DR Bgee; ENSMUSG00000035283; Expressed in parotid gland and 141 other cell types or tissues. DR GO; GO:0005769; C:early endosome; ISS:UniProtKB. DR GO; GO:0016020; C:membrane; IMP:MGI. DR GO; GO:0098992; C:neuronal dense core vesicle; IDA:SynGO. DR GO; GO:0005886; C:plasma membrane; ISS:UniProtKB. DR GO; GO:0098794; C:postsynapse; IEA:GOC. DR GO; GO:0098685; C:Schaffer collateral - CA1 synapse; IDA:SynGO. DR GO; GO:0031694; F:alpha-2A adrenergic receptor binding; ISO:MGI. DR GO; GO:0043176; F:amine binding; ISO:MGI. DR GO; GO:0004940; F:beta1-adrenergic receptor activity; IDA:MGI. DR GO; GO:0099579; F:G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential; IDA:SynGO. DR GO; GO:0030165; F:PDZ domain binding; ISO:MGI. DR GO; GO:0046982; F:protein heterodimerization activity; ISO:MGI. DR GO; GO:0071880; P:adenylate cyclase-activating adrenergic receptor signaling pathway; ISS:UniProtKB. DR GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IMP:MGI. DR GO; GO:0050873; P:brown fat cell differentiation; IGI:MGI. DR GO; GO:0002024; P:diet induced thermogenesis; IGI:MGI. DR GO; GO:0042596; P:fear response; IMP:MGI. DR GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISO:MGI. DR GO; GO:0005980; P:glycogen catabolic process; ISO:MGI. DR GO; GO:0031649; P:heat generation; IGI:MGI. DR GO; GO:0060080; P:inhibitory postsynaptic potential; ISO:MGI. DR GO; GO:0055088; P:lipid homeostasis; ISO:MGI. DR GO; GO:0007613; P:memory; ISO:MGI. DR GO; GO:0040015; P:negative regulation of multicellular organism growth; IGI:MGI. DR GO; GO:0045986; P:negative regulation of smooth muscle contraction; ISO:MGI. DR GO; GO:0035811; P:negative regulation of urine volume; ISO:MGI. DR GO; GO:0002025; P:norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure; IMP:MGI. DR GO; GO:0106071; P:positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway; ISO:MGI. DR GO; GO:0043065; P:positive regulation of apoptotic process; ISO:MGI. DR GO; GO:1905665; P:positive regulation of calcium ion import across plasma membrane; ISO:MGI. DR GO; GO:0061051; P:positive regulation of cell growth involved in cardiac muscle cell development; ISO:MGI. DR GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; IMP:YuBioLab. DR GO; GO:0043547; P:positive regulation of GTPase activity; ISS:UniProtKB. DR GO; GO:0010460; P:positive regulation of heart rate; ISO:MGI. DR GO; GO:0001996; P:positive regulation of heart rate by epinephrine-norepinephrine; IMP:MGI. DR GO; GO:1900273; P:positive regulation of long-term synaptic potentiation; ISO:MGI. DR GO; GO:0003084; P:positive regulation of systemic arterial blood pressure; ISO:MGI. DR GO; GO:0001997; P:positive regulation of the force of heart contraction by epinephrine-norepinephrine; IDA:MGI. DR GO; GO:0003061; P:positive regulation of the force of heart contraction by norepinephrine; ISO:MGI. DR GO; GO:0033365; P:protein localization to organelle; ISO:MGI. DR GO; GO:0051924; P:regulation of calcium ion transport; ISO:MGI. DR GO; GO:0086004; P:regulation of cardiac muscle cell contraction; ISO:MGI. DR GO; GO:0045187; P:regulation of circadian sleep/wake cycle, sleep; IMP:UniProtKB. DR GO; GO:0009409; P:response to cold; IGI:MGI. DR GO; GO:0007266; P:Rho protein signal transduction; ISO:MGI. DR CDD; cd15958; 7tmA_Beta1_AR; 1. DR Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1. DR InterPro; IPR002233; ADR_fam. DR InterPro; IPR000507; ADRB1_rcpt. DR InterPro; IPR000276; GPCR_Rhodpsn. DR InterPro; IPR017452; GPCR_Rhodpsn_7TM. DR PANTHER; PTHR24248; ADRENERGIC RECEPTOR-RELATED G-PROTEIN COUPLED RECEPTOR; 1. DR PANTHER; PTHR24248:SF54; BETA-1 ADRENERGIC RECEPTOR; 1. DR Pfam; PF00001; 7tm_1; 1. DR PRINTS; PR01103; ADRENERGICR. DR PRINTS; PR00561; ADRENRGCB1AR. DR PRINTS; PR00237; GPCRRHODOPSN. DR SMART; SM01381; 7TM_GPCR_Srsx; 1. DR SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1. DR PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1. DR PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1. DR Genevisible; P34971; MM. PE 1: Evidence at protein level; KW Cell membrane; Direct protein sequencing; Disulfide bond; Endosome; KW G-protein coupled receptor; Glycoprotein; Lipoprotein; Membrane; Palmitate; KW Phosphoprotein; Receptor; Reference proteome; Transducer; Transmembrane; KW Transmembrane helix. FT CHAIN 1..466 FT /note="Beta-1 adrenergic receptor" FT /id="PRO_0000069122" FT TOPO_DOM 1..55 FT /note="Extracellular" FT /evidence="ECO:0000250" FT TRANSMEM 56..84 FT /note="Helical; Name=1" FT /evidence="ECO:0000250" FT TOPO_DOM 85..93 FT /note="Cytoplasmic" FT /evidence="ECO:0000250" FT TRANSMEM 94..120 FT /note="Helical; Name=2" FT /evidence="ECO:0000250" FT TOPO_DOM 121..132 FT /note="Extracellular" FT /evidence="ECO:0000250" FT TRANSMEM 133..154 FT /note="Helical; Name=3" FT /evidence="ECO:0000250" FT TOPO_DOM 155..172 FT /note="Cytoplasmic" FT /evidence="ECO:0000250" FT TRANSMEM 173..196 FT /note="Helical; Name=4" FT /evidence="ECO:0000250" FT TOPO_DOM 197..222 FT /note="Extracellular" FT /evidence="ECO:0000250" FT TRANSMEM 223..248 FT /note="Helical; Name=5" FT /evidence="ECO:0000250" FT TOPO_DOM 249..308 FT /note="Cytoplasmic" FT /evidence="ECO:0000250" FT TRANSMEM 309..338 FT /note="Helical; Name=6" FT /evidence="ECO:0000250" FT TOPO_DOM 339..343 FT /note="Extracellular" FT /evidence="ECO:0000250" FT TRANSMEM 344..366 FT /note="Helical; Name=7" FT /evidence="ECO:0000250" FT TOPO_DOM 367..466 FT /note="Cytoplasmic" FT /evidence="ECO:0000250" FT REGION 264..302 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 398..466 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 463..466 FT /note="PDZ-Binding" FT /evidence="ECO:0000250" FT COMPBIAS 270..286 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 438..466 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 296 FT /note="Phosphoserine; by PKA" FT /evidence="ECO:0000255" FT MOD_RES 301 FT /note="Phosphoserine; by PKA" FT /evidence="ECO:0000255" FT MOD_RES 401 FT /note="Phosphoserine; by PKA" FT /evidence="ECO:0000255" FT MOD_RES 417 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P18090" FT LIPID 381 FT /note="S-palmitoyl cysteine" FT /evidence="ECO:0000250" FT CARBOHYD 15 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000305" FT DISULFID 131..216 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00521" FT DISULFID 209..215 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00521" FT MUTAGEN 187 FT /note="A->V: In knockin mouse model, decreases protein FT levels. Mice exhibit a short sleep phenotype. Changes the FT electrophysiological properties of dorsal pons neurons." FT /evidence="ECO:0000269|PubMed:31473062" FT CONFLICT 65 FT /note="L -> V (in Ref. 1; AAA02929)" FT /evidence="ECO:0000305" SQ SEQUENCE 466 AA; 50494 MW; E4861E250B62F735 CRC64; MGAGALALGA SEPCNLSSAA PLPDGAATAA RLLVLASPPA SLLPPASEGS APLSQQWTAG MGLLLALIVL LIVVGNVLVI VAIAKTPRLQ TLTNLFIMSL ASADLVMGLL VVPFGATIVV WGRWEYGSFF CELWTSVDVL CVTASIETLC VIALDRYLAI TSPFRYQSLL TRARARALVC TVWAISALVS FLPILMHWWR AESDEARRCY NDPKCCDFVT NRAYAIASSV VSFYVPLCIM AFVYLRVFRE AQKQVKKIDS CERRFLGGPA RPPSPEPSPS PGPPRPADSL ANGRSSKRRP SRLVALREQK ALKTLGIIMG VFTLCWLPFF LANVVKAFHR DLVPDRLFVF FNWLGYANSA FNPIIYCRSP DFRKAFQRLL CCARRAACRR RAAHGDRPRA SGCLARAGPP PSPGAPSDDD DDDAGTTPPA RLLEPWTGCN GGTTTVDSDS SLDEPGRQGF SSESKV //